Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Renal Cell 4Carcinoma, Non-Small-Cell Lung 2Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Prostatic Neoplasms 1Neoplasms 1Metastatic Non-Squamous Non-Small Cell Lung Cancer 1Melanoma 1Lung Neoplasms 1Liposarcoma 1Head and Neck Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Hepatocellular 1Carcinoma 1Advanced or Metastatic Solid Malignancies 1Advanced Solid Tumors 1Advanced Solid Tumor 1Advanced Malignancies 1Adenocarcinoma 1

Interventions

Doxorubicin 14Radiotherapy 10Ifosfamide 10Trabectedin 7pazopanib 4Imatinib Mesylate 3Filgrastim 3Etoposide 3Cyclophosphamide 3Chemotherapy, Adjuvant 3temsirolimus 2romidepsin 2ribociclib 2pegfilgrastim 2eribulin 2cixutumumab 2brigimadlin 2belinostat 2Vincristine 2Sunitinib 2Radiotherapy, Conformal 2Gemcitabine 2Epirubicin 2Dexamethasone 2Dactinomycin 2Carboplatin 2soblidotin 1sitravatinib 1siremadlin 1selinexor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Liposarcoma × sitravatinib × Clear all
NCT02978859 2024-07-18

Sitravatinib in Advanced Liposarcoma and Other Soft Tissue Sarcomas

Columbia University

Phase 2 Completed
29 enrolled 11 charts
Sarcoma

Liposarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡